IP Library Granted Patent US 7,918,847
Granted Patent B2
US 7,918,847 · App. 11/214,256 · Granted Apr 5, 2011

Method and associated system for the interventional treatment of atrial fibrillation

Assignee: Washington University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,918,847
App. No.
11/214,256
Granted
Apr 5, 2011
Kind
B2
Abstract

A method for treatment of atrial fibrillation includes utilizing mathematical analysis, e.g., logistic regression, on a collection of variables selected from the group including effective refractory period, wavelength, tissue area, tissue weight, maximum tissue width, minimum tissue width, and average tissue width to design a set of lesions that would make an atria fibrillation-proof. Preferably, the most preferred variables are tissue area, effective refractory period, and conduction velocity. This is preferably an electrophysiologically-customized procedure that is preferably minimally invasive, which could include transvenous or port access, either off or on bypass to create the set of lesions that render an atria fibrillation-proof based on the mathematical analysis of selected variables. Long linear lesions are created from a variety of energy sources as well as surgical techniques. Preferably, there are fixation and marking mechanisms utilized.

Claims (15)

1. A method for treating atrial fibrillation comprising:

obtaining at least one measurement with a measurement device associated with an atria selected from the group consisting of effective refractory period, wavelength, tissue surface area, tissue weight, maximum tissue width, minimum tissue width, average tissue width, conduction velocity and maximum conduction velocity;

performing a multivariable logistic regression analysis, with a processor, to determine atrial tissue section areas that will prevent atrial fibrillation;

designing a set of lesions based on probabilities generated from the multivariable logistic regression analysis that provided the atrial tissue section areas;

creating the designed lesions with a cutting or ablation device to obtain the atrial tissue section areas in order to significantly reduce the probability of sustained atrial fibrillation, wherein the multivariable logistic regression analysis includes the equation for determining atrial fibrillation being:

AF=exp (x) /[1+exp (x) ] where x=constant+β 0 (variable 1)+β 1 (variable 2) and x is selected from the group consisting of effective refractory period, wavelength, tissue area, tissue weight, maximum tissue width, minimum tissue width, average tissue width, conduction velocity and maximum conduction velocity and β 0 and β 1 are constants; wherein AF is the probability of atrial fibrillation so that if an acceptable probability of atrial fibrillation is utilized, a value for the variable 1 and the variable 2 can be determined.

2. The method for treating atrial fibrillation as set forth in claim 1 , wherein the step of obtaining at least one measurement with a measurement device associated with an atria selected from the group consisting of effective refractory period, wavelength, tissue surface area, tissue weight, maximum tissue width, minimum tissue width, average tissue width, conduction velocity and maximum conduction velocity includes utilizing computerized axial tomography scanning or magnetic resonance imaging.

3. The method for treating atrial fibrillation as set forth in claim 1 , wherein the creating lesions with a cutting device in the locations of the secured atrial epicardium to treat atrial fibrillation includes utilizing a mechanism selected from the group consisting of cutting devices that include a device that utilizes radio frequencies, a device that utilizes microwaves, a laser, a device that utilizes ultrasound, a device that utilizes thermal energy, a device that utilizes at least one chemical, a mechanical cutting device, or a device that utilizes cryogenics.

4. The method for treating atrial fibrillation as set forth in claim 1 , further comprising marking to delineate lesion width.

5. The method for treating atrial fibrillation as set forth in claim 4 , wherein the marking to delineate lesion width includes utilizing at least one dye, at least one clip, at least one absorbable strip, felt or at least one staple.

6. The method for treating atrial fibrillation as set forth in claim 1 , further comprising dividing posterior pericardial reflections.

7. The method for treating atrial fibrillation as set forth in claim 6 , wherein the dividing posterior pericardial reflections further includes retracting a heart with a heart retraction device.

8. The method for treating atrial fibrillation as set forth in claim 6 , wherein the dividing posterior pericardial reflections further includes retracting a heart with a heart retraction device having a retractable handle.

9. The method for treating atrial fibrillation as set forth in claim 6 , wherein the dividing posterior pericardial reflections includes dividing posterior pericardial reflections with a device to divide the pericardium.

10. The method for treating atrial fibrillation as set forth in claim 9 , wherein the dividing posterior pericardial reflections with a device to divide the pericardium includes utilizing a cautery, an ultrasound or at least one pair of scissors.

Assignments (2)
CONFIRMATORY LICENSE Recorded Nov 18, 2016
From: WASHINGTON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040648/0603 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2005
From: DAMIANO JR., RALPH J.; SCHUESSLER, RICHARD B.
To: WASHINGTON UNIVERSITY
Reel/Frame 016932/0988 →
Continuity (1)
Related Publication 20070049816A1 · Mar 1, 2007